Using recombinant Chlamydia trachomatis OMP2 as antigen in diagnostic ELISA test.

Area of Science:

• Microbiology
• Immunology
• Infectious Diseases

Background:

• Chlamydia trachomatis is a significant cause of sexually transmitted infections.
• Accurate and sensitive detection methods are crucial for managing C. trachomatis.
• Existing diagnostic methods often suffer from cross-reactivity issues.

Purpose of the Study:

• To develop a more specific antigen for serological detection of C. trachomatis.
• To evaluate the diagnostic performance of a recombinant C. trachomatis OMP2 antigen in ELISA.

Main Methods:

• Sera from 192 women with suspected chlamydial infection were analyzed.
• An ELISA system was developed using recombinant C. trachomatis OMP2 as the antigen.
• The assay's performance was validated against a commercial kit and tested for cross-reactivity.

Main Results:

• The recombinant OMP2 ELISA demonstrated a sensitivity of 90% and specificity of 86%.
• The assay showed no cross-reactivity with sera from patients infected with various other pathogens.
• The developed ELISA identified 15.62% positive and 84.37% negative cases.

Conclusions:

• Recombinant C. trachomatis OMP2 is a viable antigen for ELISA-based serological tests.
• The developed ELISA offers good sensitivity and specificity for C. trachomatis detection.
• Further comparison with commercial kits indicates potential for improved diagnostic accuracy.